The majority of our life time is spent in indoor environments, but little is known about the bacterial communities with which we share indoors. Recently, the application of next generation sequencing techniques has allowed new insight into indoor microbial communities. In general, they are characterized by a high prokaryotic diversity and are comprised of diverse bacterial and archaeal phyla[@b1][@b2][@b3][@b4]. Indoor microbiomes originate mainly from the human skin or from outside air, and have even been known to include extremophiles. Furthermore, all of them contain potential human pathogens, but also beneficial bacteria that are characterized by a positive interaction with their host[@b1][@b3]. Kembel *et al*.[@b3] were the first to analyze patient rooms and find a strong effect from both architecture and ventilation. In contrast to the majority of indoor environments, rooms in hospitals and especially intensive care units (ICUs) are routinely monitored[@b5]. Standard cultivation techniques, such as contact plates, are commonly used to monitor the microbial burden. However, culture collections contain a restricted spectrum and only a very small proportion of the total bacteria as already described in 1985 by Staley and Konopka[@b6]. A comparison of the bacterial diversity obtained by standard monitoring and next generation sequencing techniques in ICUs has unfortunately not yet been published. We hypothesize that the ICU microbiome is characterized by a much higher bacterial diversity and abundance than is currently thought.

Indoor microbial communities are an important component of everyday human health[@b3][@b7], and are even partially composed of human-associated bacteria[@b1] due to the high emission rate of up to 10^6^ bacteria per person-hour[@b8]. In ICUs, sanitation protocols are stricter than in other areas of the hospital, yet many patients treated in ICUs are infected with hospital-acquired "nosocomial infections" often due to an underlying severe disease[@b9][@b10]. Moreover, these nosocomial infections remain among the leading causes of death in hospitals of developed countries. For example, they are a significant cause of morbidity and mortality in the United States; 1.7 million infections resulting in 99,000 deaths were reported in 2002[@b11]. In Europe, the risk for nosocomial infections for patients in ICUs is reported as 45%[@b9]. Hospital surfaces are often overlooked reservoirs for this bacteria[@b12][@b13][@b14], thus new sanitation standards are needed to drastically reduce this risk for hospital-acquired infections[@b15]. New sequencing techniques will allow for a greater understanding of whole ICU bacterial communities, including their beneficials, and contribute to a new perspective on hospital sterility.

The objective of this work was to analyse the structure of bacterial communities from the ICU of the Department of Internal Medicine at the University Hospital in Graz/Austria using a comparative approach between currently used standard cultivation of the ICU and 16S rRNA gene amplicon sequencing. Altogether, 34 surface samples obtained from three general areas (floors, medical devices, workplaces) inside the ICU were studied. 16S rRNA gene amplicons and isolates were identified and compared by a principal coordinate analysis. In addition, network analysis using Cytoscape 2.8 software[@b16] was performed to identify the most abundant taxa and to compare their abundance across the three sampling areas.

Results
=======

Structure and diversity of bacterial community profiles
-------------------------------------------------------

From all surface samples of the three areas within the ICU - the floor environment (A: 5 samples), devices (B: 11 samples) and workplaces (C: 8 samples) - visualized in [Fig. 1](#f1){ref-type="fig"} - a high number of amplicons were obtained and sequenced. In total, the raw dataset of all 24 samples contained 356,571 sequences. After trimming, the final operational taxonomic unit (OTU) table consisted of 308,440 sequences. The docking station (MID53) contained the highest (16,137) and the floor of the patient room after cleaning (MID35) the fewest (5,321) amount of sequences respectively. Due to the different number of sequences among samples, the data was normalized to 5,321 sequences.

The composition of microbial communities included 7 different bacterial phyla: *Acidobacteria*, *Actinobacteria*, *Bacteroidetes*, *Cyanobacteria*, *Firmicutes*, *Nitrospira* and *Proteobacteria*. *Proteobacteria* (64%) was the most abundant phylum across all samples. At genus level, differences between the communities of the various areas were detected ([Fig. 2](#f2){ref-type="fig"}). The amplicon library of the ICU included sequences of 405 genera, 76 of them were reaching 1% of relative abundance. Only a minor part of sequences belonging to members of the genera *Acinetobacter*, *Bradyrhizobium*, *Burkholderia*, *Delftia*, *Enhydrobacter*, *Propionibacterium*, *Pseudomonas, Serratia*, *Staphylococcus* and *Streptococcus* were retrieved from surfaces of all three areas. [Figure 2](#f2){ref-type="fig"} also indicates that devices contained a greater variety of bacteria (23 genera) than the workplaces (15 genera) and the floor (8 genera). An overlap between the detected genera of the three areas was also observed; the highest was found between devices/workplaces (12 genera) and followed by floor/workplaces (4) and floor/devices (3). A comparison of the relative abundances confirmed differences between the three main areas ([Fig. 3](#f3){ref-type="fig"}). Most notably, *Pseudomonas* and *Propionibacterium* were clearly most abundant on all sampling sites. On the floor (A), the most frequently present genus was *Acinetobacter* (24%) among the other commonly found genera *Propionibacterium, Pseudomonas, Staphylococcus*, and *Streptococcus*. The dominant genera on devices (B) and workplaces (C) were *Pseudomonas* (4% in B, 7% in C), *Novosphingobium* (10% in B, 5% in C), *Burkholderia* (14% in B, 15% in C), *Bradyrhizobium* (16% in B, 17% in C) and *Propionibacterium* (7% in B, 5% in C). The most abundant genus on floors, *Acinetobacter,* was less present in these two areas (3% in B, 2% in C). *Chryseobacterium*, *Janthinobacterium*, *Legionella*, *Methylobacterium* and *Shigella* were minimal on devices and workplaces. *Corynebacterium* was only present in some floor samples and workplaces, whereas *Serratia* was measured in low numbers in several samples of all areas. *Gemella*, *Flavobacterium* and *Stenotrophomonas* were only detected on several devices, while *Bacillus*, *Granulicatella* and *Nitrospira* were all observed in relatively high abundances. Taxonomic classification of each sampling site is shown in [Fig. S1](#s1){ref-type="supplementary-material"}.

To determine richness and diversity, OTUs were identified at genetic distances of 3% (species level), 5% (genus level) and 20% (phylum level) by using quality sequences with a read length of ≥ 150 bp per sample. At 20% sequence divergence, most rarefaction curves showed saturation, indicating that the surveying effort covered almost the full extent of taxonomic diversity at this genetic distance ([Fig. S2](#s1){ref-type="supplementary-material"}). Comparison of the rarefaction analyses with the number of OTUs determined by the Chao1 richness estimator revealed that 83% to 100% (20% genetic distance) of the estimated taxonomic richness was detected. At 3% and 5% genetic distance, the rarefaction curves were not saturated and the richness estimators indicated that 45% to 78% and 47% to 84% of the estimated richness were recovered. As a result, we did not survey the full extent of taxonomic diversity at these genetic distances, but a substantial fraction of the bacterial diversity within individual samples was assessed at species and genus level. The Shannon index of diversity (H′) was determined for all samples ([](#t1){ref-type="table"}[Table 2](#t2){ref-type="table"}). The highest bacterial diversity at a genetic distance of 3% was found on workplaces (3.46), followed by the floor (3.14) and devices (3.0). The Shannon index of each sampling site ranged from 2.29 to 4.64; the surfaces of the bandage trolley (MID38) and workplaces of the patient room (MID37) showed the highest diversity.

Differences between the bacterial community profiles
----------------------------------------------------

Using the software package QIIME[@b17], the final OTU table for principal coordinate analysis (PCoA) comprised 3,925 OTUs and was distributed into 556 OTUs represented by more than 10 sequences. Beta diversity of the bacterial communities within the ICU revealed clear distinctions between bacterial populations among the three areas. Floor-associated bacterial communities formed clusters distinct from devices ([Fig. 4](#f4){ref-type="fig"}), while the analyzed samples from workplaces and devices were similar. Samples from workplaces of the patient room (MID37) and bandage trolley (MID38) were significantly differentiated from those of the other workplaces and were closer to samples from the floor. Furthermore, the structure of the bacterial community found on the docking station (MID53) was completely distinct from other communities.

To gain better insight into the differences of the three areas, we applied a profile clustering network analysis ([Fig. 5](#f5){ref-type="fig"}). This profile obtained by a Cytoscape network analysis showed the most abundant 40 OTUs and highlighted the relative distribution and abundances. *Acinetobacter* was the most abundant and ubiquitous bacterial genus with dominant occurrence on the floor. In addition, *Bradyrhizobium* and *Burkholderia* were among the dominant genera of all areas.

According to the statistical analysis, 330 out of 3,925 examined OTUs showed significant differences between the floor environment (A) and devices (B), and 336 between devices (B) and workplaces (C). A comparison of the floor environment (A) and the workplaces (C) resulted in a statistically significant difference between species for 155 OTUs. Statistical analysis of data is shown in Tab. S1. Most notably, in numerous samples of the floor environment (up to 59%) and in some samples from devices and workplaces, the relative abundance of *Unclassified* was particularly high. Comparison of the relative abundances indicated a correlation of Cyanobacteria at phylum level with the *Unclassified* at genus level. Additional BLAST analysis of the *Unclassified* detected that most sequences classified as Cyanobacteria-like are chloroplast sequences that originate from Pinaceae and from other plant components. Sequences were affiliated to species of conifer in the Pinaceae family containing *Abies* sp., *Larix* sp., *Picea* sp. or *Pinus* sp. with maximal identity of 99% and originated from *Pinus* pollen from outside air. Abundance of chloroplast sequences is shown in Tab. S2.

Comparison between standard cultivation and 16S pyrosequencing
--------------------------------------------------------------

Comparative samples were taken from 10 sampling sites of defined positions on devices and workplaces ([Table 1](#t1){ref-type="table"}). The colonies showed a low diversity in their morphology and colour (white approx. 80%; the others yellow and red). The highest number of colonies (512) was found on the keyboard in the central nurse station, but only two colonies were detected on the workplace of the patient room. The number of colony forming units (CFUs) of all sampling sites is listed in [Table 1](#t1){ref-type="table"}.

A total of 130 isolates obtained from contact plates were characterized by ARDRA (amplified ribosomal RNA gene restriction analysis using *Hha*I) and divided into 36 ARDRA groups at a cutoff level of 85%. Representative strains of each group were partially sequenced and identified by their 16S rRNA; the genera *Aerococcus*, *Arthrobacter*, *Bacillus*, *Corynebacterium*, *Kocuria*, *Micrococcus*, *Paenibacillus*, *Planomicrobium*, *Roseomonas* and *Staphylococcus* were identified. Twelve ARDRA groups include the majority of isolates and were identified as species belonging to the genus *Staphylococcus*. In contrast, 21 groups were represented by only one isolate. To analyze the genotypic diversity within the ARDRA groups at population level, BOX-PCR patterns of the whole bacterial genome were used. At 80% similarity, 24 unique populations were differentiated ([Table 3](#t3){ref-type="table"}). With the exception of the *Roseomonas mucosa* strain (ARDRA group 34), only Gram-positive species were found; 49 of them were identified as *Staphylococcus epidermidis* and *Staphylococcus hominis*. Other *Staphylococcus* sequences were classified as *S. auricularis*, *S. caprae*, *S. cohnii,* *S. haemolyticus*, *S. lugdunensis* and *S. warneri*. Less retrieved sequences belonged to *Micrococcus antarcticus, M. luteus, Arthrobacter agilis, Bacillus circulans, B. idriensis* and *Kocuria palustris.* Furthermore, a few sequences were identified as *Aerococcus urinaeequi*, *Bacillus aerophilus*, *B. frigoritolerans*, *B. herbersteinensis*, *B. simplex*, *Corynebacterium propinquum*, *Kocuria rosea*, *Paenibacillus barcinonensis*, *Planomicrobium koreense* and *Roseomonas mucosa*. Interestingly, the keyboard of the central nurse station showed the highest number of CFUs (512) containing six different species. In comparison, the respirator from the patient room contained only 15 colonies, but nine different species were identified. Isolates with identical and similar BOX patterns were detected on nearly all sampling sites ([Fig. 6](#f6){ref-type="fig"}) indicating transmission between them or deposition of bacteria from identical or similar sources.

Culture-dependent identification was compared with 16S rRNA gene 454-pyrosequencing analysis. While OTUs taken from the amplicon libraries were affiliated with 405 different genera (76 genera ≥ 1% of relative abundance), standard cultivation obtained only 10 bacterial genera corresponding to 2.5% of the total bacterial diversity. Most of the reference sequences of isolates presented an exact match with the pyrosequencing data, but some MIDs did not reach 1% of the relative abundance. Complete linkage clustering indicated that sequences of *Micrococcus luteus* (Sequence ID: 43/6; max. identity: 92%), *Corynebacterium propinquum* (49/11; 99%) and *Bacillus aerophilus* (43/16; 79%) were not present in the cultivation-independent data because their similarity values were lower ([Table 3](#t3){ref-type="table"}) in comparison to the other sequences.

Discussion
==========

In this study we found a much higher diversity of bacterial communities in the ICU by using the 16S pyrosequencing approach than compared to the standard cultivation technique. Distinct profiles between the floor environment, medical devices and workplaces were found using both strategies. However, various ubiquitous taxa as well as genotypically identical strains were frequently observed.

Although the surfaces in ICUs were characterized by highly diverse bacterial communities, they were actually reduced in comparison with other indoor environments such as living, patient, class or rest rooms[@b3]. Similar to other indoor microbial communities, these communities were partially colonized by human-associated bacteria. Although it is impossible to predict the pathogenicity of a strain based on 16S rRNA sequences, the proportion of bacteria identified as those genera/species closely related to human pathogens was very high. They are known for their facultative pathogenic and nosocomial character, e.g. *Acinetobacter,* *Stenotrophomonas*, *Burkholderia, Flavobacterium, Propionibacterium, Pseudomonas, Staphylococcus* and *Escherichia/Shigella*[@b18][@b19]. Humans are not only the most important dispersal vectors for bacteria inside rooms[@b11]; their bacterial fingerprint represents a unique mix of bacteria including pathogens[@b20]. Therefore, patients in the ICU may have contributed to this high proportion of potential pathogens. To evaluate this hypothesis, we compared our data with the infections acquired by patients during this time (February-May 2011) in the ICU and found several overlaps which could potentially confirm the potential pathogenic character of several surface-associated bacteria. Altogether, from 101 bacterial infections, the majority was caused by *Staphylococcus* (40; *S. aureus, S. epidermidis* and spec. div.). However, Gram-negative pathogens were also identified, e.g. according to their abundance: *E. coli, Klebsiella, Pseudomonas, Serratia, Enterobacter, Edwardsiella, Proteus* and *Chryseobacterium*. Conversely, we found bacterial genera, e.g. *Burkholderia*, *Pseudomonas*, *Lactobacillus*, or *Methylobacterium* which contain plant-associated taxa that can also undergo bivalent interactions with humans. Although they can cause facultative infections in those with certain predispositions, they can also live in symbiosis with plants or can be used as pro- and prebiotics for both plants and humans[@b21][@b22][@b23][@b24]. Their origin and function in hospital environments is still unclear. However, one method of transmission could be the transport via pollen into the hospital environment due to the detection of pollen as a vector for specific plant-associated bacteria[@b25]. We found a high proportion of chloroplast sequences from *Pinus* pollen - *Pinus* trees were among the most common plants outside - in the floor environment and on several devices. These sequences were also detected and discussed in other pyrosequencing-based studies[@b1][@b3]. In addition to air conditioning, the investigated ICU was also window-ventilated, which has been known to result in an increased abundance of chloroplast DNA than in exclusively mechanically ventilated rooms[@b3].

The bacterial communities from three general area floors, medical devices, and workplaces were characterized by a specific and distinct composition. Skin-associated genera (*Propionibacterium*, *Corynebacterium*, *Staphylococcus*, *Streptococcus*, *Bradyrhizobium*)[@b26] were highly abundant on medical devices and working surfaces, which was expected considering that they are frequently touched by hands of hospital staff: a typical hand surface harbored on average more than 150 unique species-level bacterial phylotypes[@b20]. Interestingly, genera of *Burkholderia* and *Bradyrhizobium* were most abundant on devices and workplaces and are both originally plant-associated genera with the potential to fix nitrogen, but are also able to colonize hospital water supplies and surfaces[@b27]. In contrast, the floor environment contained genera that are typically distributed in environmental sources, such as soil or water. *Acinetobacter* was the dominant genus of the floor sample but was also present on almost all devices. During recent years, antibiotic-resistant *Acinetobacter* infections have become an increasingly common nosocomial problem[@b28][@b29]. Another emerging nosocomial pathogen *Clostridium difficile* was fortunately not detected in our amplicon libraries. Due to its long-living spores, this bacterium is often found and can cause large-scale outbreaks of nosocomial diarrhea[@b5].

Although bacterial communities in the ICU could be effectively differentiated, connections and transmissions were also detected by principal coordinate- and network analyses. For example, samples of the bandage trolley (MID38) and the workplace in the patient room (MID37) are located between clusters of devices and floor. This bandage trolley is used the whole day in several rooms by different persons of the staff. Additionally, the workplace of the patient room is frequently in contact with the hospital staff, which can explain the transfer. In addition, these two sampling sites were characterized by the highest bacterial diversity (Shannon diversity indices: MID38 4.64; MID37 4.11). Transmission of bacteria from one site to the other was also found comparing molecular fingerprints of the isolated strains. For example, similar BOX fingerprints of staphylococci were identified on nearly all sampling sites. However, deposition of bacterial strains from identical or similar sources, e.g. by personal staff, can also explain this finding. Surface sanitation is an often overlooked, yet crucial component of transmission[@b15], which should be considered more in sanitation protocols. No differences were observed between the bacterial communities of the isolation room for patients who were temporarily isolated with the risk of spreading an infectious disease or were severely immunocompromised and the other patient rooms. This observation is most likely because the isolation room was not in use at the time of sampling.

Although it is well-known that cultivation-dependent techniques capture only a small part of the microbiome[@b6][@b30], we found an unexpected high difference between the bacterial diversity using both methods -- standard cultivation and amplicon sequencing. While in the 16S rRNA gene amplicon library the amount of Gram-positive and Gram-negative bacteria was nearly the same, we detected almost exclusively Gram-positive bacteria by cultivation. With the exception of *Roseomonas mucosa* known to be associated with bacteremia and other human infections[@b31], cultivation failed to capture the Gram-negative spectrum. This similar proportion of Gram-negative and Gram-positive bacteria as in our libraries was also found in the bacterial infections acquired during this time in the ICU. While the Gram-positive spectrum comprised mainly *Staphylococcus* and *Enterococcus* species, the Gram-negative pathogens were characterized by a higher taxonomic diversity. The Gram-positive diversity was well represented in the isolate collection, where the majority of the obtained cultivation-based sequences belonged to *Staphylococcus (S. epidermidis, S. hominis, S. auricularis*, *S. caprae, S. cohnii*, *S. haemolyticus*, *S. lugdunensis,* *S. warneri)*, which are already described as the most common bacteria in hospitals. Several of them such as *S. epidermidis,* *S. haemolyticus* or *S. warneri* emerged as causal agents of nosocomial infections with diverse resistances against antibiotics[@b32]. Interestingly, identical 16S rRNA gene sequences were found for isolates as well as in the amplicon library. Moreover, all sequences from isolates could be found in the amplicon libraries. However, due to the fact that the cultivation of Gram-negatives ultimately failed, new standard protocols should be developed to assess the overall diversity. For this cultivation, we used CASO agar plates that are synonymous to Tryptic Soy Agar (TSA) and Soybean Casein Digest Agar (CSA) suggested by both the European (EP) and United States Pharmacopoeia (USP). While it is difficult to explain why colonies of the well-cultivable bacteria genera such as *Burkholderia* and *Pseudomonas* were not isolated from plates, our cultivation results were highly similar to those obtained from the weekly routine monitoring and our 16S amplicon library was comparable with other pyrosequencing based studies[@b1][@b2][@b3][@b4]. However, we must consider that pyrosequencing based on DNA may also detect DNA from non-living and living bacteria. Light-activated ethidium monoazide or propidium monoazide can help to remove free extracellular DNA from environmental samples in the future[@b33].

In support of our hypothesis, we found an unexpected high diversity from the bacterial communities with bacteria closely related to human pathogens, but also taxa known for their beneficial interaction with eukaryotes. By using 16S pyrosequencing and corresponding network analysis, we have the tools to evaluate existing sanitation concepts. We suggest that the whole bacteria community should be considered in the assessment of these concepts because diversity within these communities often correlates with the ecosystem function of disease suppression[@b34]. If this can be proved for indoor microbiomes, the demand to "Stop killing beneficial bacteria" by Blaser[@b35] should be expanded.

Methods
=======

Experimental design and sampling procedure
------------------------------------------

Samples were taken from selected surface areas and devices of the intensive care unit (ICU, Department of Internal Medicine, University hospital) in Graz/Austria. The intensive care unit contains 15 beds, including one isolation unit for severe immunocompromised patients. In this ICU the critically ill patients from all internal medicine subspecialities as well as neurologic patients are treated. All sampling locations and their characteristics are given in [Table 1](#t1){ref-type="table"}. During sampling, all employees and devices of the ICU were in full operation and eight large surface samples (1 m^2^) were performed by using biological sampling kits (BiSKits; QuickSilver Analytics, Abingdon, MD, USA). For wet sampling of 1 m^2^, BiSKits were premoistened with the manufacturer-provided sterile buffer[@b36] and the selected area was wiped in three different directions while rotating the sampling device[@b2]. Afterwards, samples were stored and chilled (4 to 8°C) during transportation, and frozen immediately at −70°C upon arrival at the laboratory.

Nylon flocked swabs (MicroRheologics, Copan, Brescia, Italy) were used to take samples of 16 devices. For sampling, swabs were moistened briefly in a 15 ml Falcon test tube containing 2.5 ml of sterile water[@b37]. After sampling of provided surfaces (5 × 5 cm), the swabs were broken into the Falcon test tubes and were kept cool (4 to 8°C). In the laboratory, microorganisms were extracted by vortexing (5 seconds) and sonication (84 W; 35 kHz; Sonorex super DK) for 120 seconds. Lastly, all samples were stored at −70°C. In addition, samples for cultivation were taken using CASO agar plates (Heipha Diagnostika, Eppelheim, Germany). In our study, ten contact tests of these CASO plates were performed according to the guidelines of the quarterly controls of the ICU. Samples were taken on defined positions and incubated at room temperature (RT) for 4 days. Colony forming units (CFU) were counted and 130 isolates were selected and subcultured on CASO agar. The isolates were purified and stored at −70°C in a nutrient broth (NB) containing 50% glycerol.

Total community DNA isolation
-----------------------------

UV sterilized Amicon Ultra-15 filters (cutoff 50 kDa; Millipore GmbH, Schwalbach, Germany) were used for concentration of the sampling liquid from BiSKits. The resulting BiSKit suspension of each sampling liquid from swabs were subjected to DNA extraction using the modified XS buffer method[@b2]: XS buffer (2 x) was freshly prepared as follows: (20 ml stock solution): 1 M Tris/HCl (pH 7.4) (4 ml); 7 M ammonium acetate (4.56 ml); 250 mM ethylene diamine tetraacetic acid (3.2 ml); 10% sodium dodecyl sulfate (w/v) (4 ml); potassium ethyl xanthogenate (0.4 g); PCR-grade water (4.99 ml). For completely dissolving the xanthogenate, the buffer was incubated at 65°C for 15 min. Starting with 1 ml sample, in total, 1 ml of 2 × XS buffer was added, and the mixture was stirred gently (short vortex). After an incubation of 2 h at 65°C, and mixing by hand every 30 min, the suspension was vortexed for 10 seconds. The tube was placed on ice for 10 min and centrifuged afterwards (100 g, 5 min, 4°C). The supernatant was transferred into a PhaseLock Gel tube (Eppendorf, Hamburg, Germany), and an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added. The suspension was mixed gently and centrifuged (2000 g, 5 min, 15°C). The aqueous layer was transferred into a new tube. To precipitate DNA, the same volume of cold 100%isopropanol and 1/10 volume of 4 M ammonium acetate was added and gently mixed. After incubation at −20°C overnight, the suspension was centrifuged at 13500 g at 4°C for 30 min. The (invisible) pellet was washed with 1 ml 70% ethanol (ice cold) and centrifuged (13500 g, 30 min, 4°C). The pellet was then dried completely and dissolved in 20 μl PCR-grade water.

16S rRNA gene amplicon pyrosequencing
-------------------------------------

For pyrosequencing, the 16S rRNA gene was amplified in a nested PCR approach with the universal bacterial primer set 27f (5′-GAGTTTGATCMTGGCTCAG-3′) and 1492r (5′-AAGGAGGTGATCCANCCRCA-3′). The PCR reaction mixture (10 μl) contained 1 × Taq&Go, 0.25 μM of each primer and 1 μl of template DNA (95°C, 5 min; 30 cycles of 95°C, 30 s; 57°C, 30 s; 72°C, 90 s; and elongation at 72°C, 5 min). In a second PCR, 1 μl of the amplicon was used. 16S rRNA gene sequences were amplified by using the forward primer Unibac-II-515f (5′-GTGCCAGCAGCCGC-3) containing the 454-pyrosequencing adaptors (MIDs) and the reverse primer UnibacII927r_454 (5′-CCCGTCAATTYMTTTGAGTT-3′). Sequences of MIDs are listed in Tab. S3. The reaction mixture for the second PCR (60 μl) contained 1 × Taq&Go, 0.25 μM of each primer and 6 μl of the PCR product solution (95°C, 5 min; 32 cycles of 95°C, 20 s; 54°C, 15 s; 72°C, 30 s; and elongation at 72°C, 10 min). PCR products were purified using the Wizard SV Gel and PCR Clean-Up System (Promega, Madison, USA). The partial 16S rRNA genes were sequenced using a Roche GS FLX+ 454 pyrosequencer (GATC Biotech, Konstanz, Germany).

Sequences that were shorter than 150 bp in length or of low quality were removed from the pyrosequencing-derived data sets using the pipeline initial process of the RDP pyrosequencing pipeline (<http://pyro.cme.msu.edu>)[@b38]. Due to the different number of sequences among samples, the data was normalized. The webserver SnoWMAn 1.11 (<http://snowman.genome.tugraz.at>)[@b39] for taxonomic-based analysis was used with the following settings: analysis type: BLAT pipeline; reference database: greengenes_24-Mar-2010; rarefaction method: RDP; taxonomy: RDP; confidence threshold: 80%; include taxa covering more than: 1%. For rarefaction analysis, operational taxonomic units (OTUs) were clustered with 3% (species level), 5% (genus level) and 20% (phylum level) dissimilarity cut-offs[@b40][@b41]. Rarefaction curves were constructed by using the tools aligner, complete linkage clustering, and rarefaction of the RDP pyrosequencing pipeline. Shannon[@b42] and Chao1 indices[@b43] were calculated with the complete linkage clustering data. Principal coordinate analysis (PCoA) plots were generated using the open source software package QIIME (<http://qiime.sourceforge.net>), which allows analysis of high-throughput community sequencing data[@b17]. Network analysis was performed to visualize the most abundant taxa and to compare their abundance across the three sampling areas. The relative abundance of single OTUs was calculated for each sample and were used to generate an average value for each of the three areas. The open source software Cytoscape 2.8[@b16] was employed to visualize the 40 most abundant OTUs based on total read counts. To differentially detect abundant microbial clusters between the three areas clusters with ≥10 sequences were explored using Metastats web interface[@b44]. Bacterial populations of the ICU dataset were examined using a combination of the nonparametric t-test, exact Fisher\'s test, and the false discovery rate with 1000 permutations. P-values were determined for each cluster correspondingly.

Phylogenetic analysis of the isolates
-------------------------------------

Based on isolated colony DNA, Amplified ribosomal RNA gene restriction analysis (ARDRA) using the restriction enzyme HhaI (MP Biomedicals, Eschwege, Germany) was performed to cluster isolates with similar band pattern into genotypic groups according to Berg et al.[@b45]. Isolates with similar ARDRA patterns were clustered in one group and analyzed performing BOX-PCR fingerprinting. BOX-PCR was done using the BOX_A1R primer (5′-CTACGGCAAGGCGACGCTGACG-3′) as described by Rademaker and de Bruijn[@b46]. Computer-assisted evaluation of ARDRA- and BOX-PCR generated fingerprints were made using the GelCompar II software (version 5.1; Applied Math, Kortrijk, Belgium). Chosen isolates were identified by partial 16S rRNA gene sequencing at the sequencing core facility in Microsynth AG, Balgach, Switzerland. Obtained sequences were aligned using the NCBI sequence database and the BLAST algorithm. The 16S rRNA gene sequences of the isolates were deposited in the NCBI nucleotide sequence database under accession numbers HE962211-HE962235.

Author Contributions
====================

Conceived and designed the experiments: G.B., C.H., K.H.S. Performed the experiments: L.O., C.Z. Analyzed the data: L.O., S.L., G.B. Wrote the first draft of the manuscript: L.O., G.B. Contributed to the writing of the manuscript: L.O., C.H., G.B., I.C.M.J.E. criteria for authorship read and met: L.O., C.Z., S.L., C.H., K.H.S., G.B. Agree with manuscript results and conclusions: L.O., C.Z., S.L., C.H., K.H.S., G.B.

Supplementary Material {#s1}
======================

###### Supplementary Information

The ignored diversity: complex bacterial communities in intensive care units revealed by 16S pyrosequencing

We thank Anastasia Bragina (Graz) and Christine Moissl-Eichinger (Regensburg) for fruitful discussions and valuable technical support. Furthermore, we would also like to thank Meg Starcher (Graz/Washington) for English revision of the manuscript. This work has been supported by a grant to G.B. from the Federal Ministry of Economy, Family and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation and Technology (bmvit), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG.

![Cartoon illustration showing each sampling site of the intensive care unit (ICU).\
Origin of the single samples is explained in [Table 1](#t1){ref-type="table"}.](srep01413-f1){#f1}

![Schematic drawing showing the detected bacterial genera found in the three different areas (floor, devices and workplaces) in the intensive care unit (ICU).\
Overlaps between the facilities are indicated by the arrangement of the circles.](srep01413-f2){#f2}

![The bacterial communities of the floor environment (A), medical devices (B) and workplaces (C).\
Relative clone composition of genera was determined by pyrosequencing of 16S rRNA from metagenomic DNA extracted from the intensive care unit. The identification of the closest strain based on 16S rRNA sequence similarity was achieved using the web server SnoWMAn 1.11 (<http://snowman.genome.tugraz.at>). Phylogenetic groups accounting for 1% of all quality sequences are summarized in the artificial group *Other*. Multi-colored charts at the legend are shown for each genus and sample correspondingly.](srep01413-f3){#f3}

![Bacterial communities associated with different areas of the intensive care unit by principal coordinate analysis (PCoA).\
Two- (A) and three-dimensional (B) PCoA plot based on the weighted UniFrac distance matrix. Percentage of the diversity distribution explained by each axes is indicated on the figure. Samples associated with the floor (green triangle), medical devices (red rectangle) and workplaces (blue points) are shown as single points.](srep01413-f4){#f4}

![Profile clustering Cytoscape network visualize the 40 most abundant OTUs across the floor (green), medical devices (red) and workplaces (blue) of the ICU.\
Node sizes correspond to the mean relative abundance between the three sampling areas where two (three) sampling groups feature the same relative abundance over the respective samples and the full nodes are subdivided into two (three) areas. A comparative node (grey) indicates the size of a node that would represent 100 reads in a sample.](srep01413-f5){#f5}

![BOX PCR fingerprints of genetically very similar *Staphylococcus* species isolated from nearly all sampling sites.\
The similarity of BOX patterns between them was more than 80%.](srep01413-f6){#f6}

###### Locations and characteristics of sampling points for cultivation-independent and -dependent methods of the intensive care unit (ICU)

  \(A\) Samples for cultivation-independent analysis                                                                                    
  ---------------------------------------------------- ----------------- ---------------------------------------------- --------------- ---------
  Entrance visitors                                          Floor                           BiSKit                           F1          MID32
  Procedure room                                             Floor                           BiSKit                           F2          MID33
  Isolation room                                             Floor                           BiSKit                           F3          MID34
  Patient room - Time 0                                      Floor                           BiSKit                           F4          MID35
  Patient room - 24 h after cleaning                         Floor                           BiSKit                           F5          MID36
  Respirator - Patient room                                 Device                     Nylon flocked swab                     D6          MID45
  Respirator - Procedure room                               Device                     Nylon flocked swab                     D7          MID46
  Respirator - Isolation room                               Device                     Nylon flocked swab                     D8          MID47
  Perfusor - Patient room                                   Device                     Nylon flocked swab                     D9          MID48
  Perfusor - Procedure room                                 Device                     Nylon flocked swab                     D10         MID49
  Perfusor - Isolation room                                 Device                     Nylon flocked swab                     D11         MID50
  Blood gas analyzer                                        Device                     Nylon flocked swab                     D12         MID51
  Docking station                                           Device                     Nylon flocked swab                     D13         MID53
  Ultrasound device                                         Device                     Nylon flocked swab                     D14         MID41
  Defibrillator                                             Device                     Nylon flocked swab                     D15         MID40
  Endoscope tip                                             Device                     Nylon flocked swab                     D16         MID52
  Workplace - Patient room                              Working Surface                      BiSKit                           W17         MID37
  Workplace - Isolation room                            Working Surface                      BiSKit                           W18         MID54
  Workplace - Bandage trolley                           Working Surface                      BiSKit                           W19         MID38
  Bandage trolley - Grasp                               Working Surface                Nylon flocked swab                     W20         MID42
  Bandage trolley in isolation room                     Working Surface                Nylon flocked swab                     W21         MID43
  Keyboard - Central nurse station                      Working Surface                Nylon flocked swab                     W22         MID55
  Keyboard - Doctors room                               Working Surface                Nylon flocked swab                     W23         MID56
  Staff Lounge                                          Working Surface                Nylon flocked swab                     W24         MID39
  **(B) Samples for cultivation-dependent analysis**                                                                                    
  **Sampling location**                                 **Description**   **Sampling tool**[2](#t1-fn2){ref-type="fn"}   **Sample ID**   **CFU**
  Workplace - Patient room                              Working Surface                   Contact test                       WS 42          2
  Workplace - Bandage trolley                           Working Surface                   Contact test                       WB 43         21
  Respirator - Patient room                                 Device                        Contact test                       RS 44         15
  Perfusor - Patient room                                   Device                        Contact test                       PS 45         210
  Keyboard - Central nurse station                          Device                        Contact test                       KO 46         512
  Keyboard - Doctors room                                   Device                        Contact test                       KD 47         48
  Blood gas analyzer                                        Device                        Contact test                       BG 48         72
  Docking station                                           Device                        Contact test                       DS 49         87
  Ultrasound device - Control panel                         Device                        Contact test                       UU 50          6
  Ultrasound device - Probe                                 Device                        Contact test                       UU 51         25

Abbreviations: BiSKit, Biological Sampling Kit; MID, Multiplex Identifier Sequence; CFU, Colony Forming Units per sample.

^1,2^ Respective sample areas were 1 m^2^ for BiSKits, 25 cm^2^ for Nylon flocked swabs and for 10 cm^2^ contact tests.

###### Species richness estimates obtained at 3%, 5% and 20% genetic dissimilarity from pyrosequencing of 16S rRNA from metagenomic DNA extracted from the floor, medical devices and workplaces

                                        Shannon index (H′)[a](#t2-fn1){ref-type="fn"}   Rarefaction[b](#t2-fn2){ref-type="fn"} (No. of OTUs)   Chao1[c](#t2-fn3){ref-type="fn"} (No. of OTUs)   Coverage (%)                                                                 
  ------------------------------------ ----------------------------------------------- ------------------------------------------------------ ------------------------------------------------ -------------- -------- ------- ---------- ---------- --------- ------ ------ -------
  Entrance visitors                                         4.09                                                3.64                                                2.24                           778.46      553.66   97.97   1713.009   1035.833   121.100   45.5   53.5   80.9
  Procedure room                                            3.03                                                2.73                                                2.08                           198.9       129.94    17     361.303    223.261    17.000    55.1   58.2   100.0
  Isolation room                                            2.29                                                2.04                                                1.24                           347.8       250.87    34     778.055    525.405    35.500    44.7   47.8   95.8
  Sick chamber - Time 0                                     3.54                                                3.02                                                2.23                           571.68      412.8    56.99   1234.414   740.217    63.429    46.3   55.8   89.9
  Sick chamber - 24 h after cleaning                        2.74                                                2.40                                                1.60                           200.9       131.94    24     354.270    222.048    26.000    56.7   59.4   92.3
  Respirator - Patient room                                 2.86                                                2.51                                                1.80                           163.94      98.97     13     210.923    117.913    13.000    77.8   84.0   100.0
  Respirator - Procedure room                               2.81                                                2.60                                                1.95                           181.92      95.98     12     294.857    116.313    12.000    61.7   82.5   100.0
  Respirator - Isolation room                               3.07                                                2.70                                                2.05                           167.93      94.97     14     233.022    122.750    17.000    72.1   77.4   82.4
  Perfusor - Patient room                                   2.97                                                2.45                                                1.58                           153.94      90.96     11     247.261    203.875    11.000    62.3   44.6   100.0
  Perfusor - Procedure room                                 3.44                                                3.13                                                2.14                           224.89      143.94    15     399.000    230.667    15.000    56.4   62.4   100.0
  Perfusor - Isolation room                                 2.89                                                2.59                                                1.90                           147.93      80.98     10     247.400     99.056    10.000    59.8   81.8   100.0
  Blood gas analyzer                                        2.90                                                2.58                                                1.82                           147.94      84.97     10     226.792    109.800    10.000    65.3   77.4   100.0
  Docking station                                           3.10                                                2.81                                                2.06                           242.9       160.95    28     397.895    220.111    29.500    61.1   73.1   94.9
  Ultrasound device                                         3.11                                                2.90                                                1.90                           181.92      119.96    16     297.161    154.440    16.000    61.2   77.7   100.0
  Defibrillator                                             2.78                                                2.38                                                1.88                           154.93      102.97    14     224.000    121.207    14.000    69.2   85.0   100.0
  Endoscope tip                                             3.00                                                2.66                                                1.85                           173.92      100.95    16     356.045    181.571    17.500    48.9   55.6   91.4
  Workplace - Patient room                                  4.11                                                3.73                                                2.44                           425.83      301.91    42     653.586    386.875    42.250    65.2   78.1   99.4
  Workplace - Isolation room                                3.05                                                2.77                                                1.75                           169.93      101.97    14     266.871    146.400    14.000    63.7   69.7   100.0
  Workplace - Bandage trolley                               4.64                                                4.24                                                2.82                           572.74      404.85   52.99   1073.039   579.690    63.500    53.4   69.9   83.5
  Bandage trolley - Grasp                                   2.94                                                2.55                                                1.61                           136.95      67.98      9     192.682     83.833     9.000    71.1   81.1   100.0
  Bandage vehicle isoltion room                             3.57                                                3.29                                                2.32                           295.86      193.93    27     539.886    299.556    27.000    54.8   64.8   100.0
  Keyboard - Central nurse station                          3.34                                                3.04                                                1.76                           181.94      111.97    15     235.318    137.143    15.000    77.3   81.7   100.0
  Keyboard - Doctors room                                   3.45                                                3.14                                                2.03                           197.92      118.96    16     306.243    153.167    16.000    64.7   77.7   100.0
  Staff Lounge                                              2.60                                                2.26                                                1.50                           141.95      74.98      7     224.650    117.857     7.000    63.2   63.6   100.0

^a^a higher number indicates more diversity.

^b^the results from the rarefaction analyses are also depicted in [Figure 4](#f4){ref-type="fig"}.

^c^nonparametric richness estimator based on the distribution of singletons and doubletons.

^d^Clusters were obtained with 3%, 5% and 20% dissimilarity cut-offs which correspond to the taxonomic level of species, genera and phyla.

###### Cultivation dependent ARDRA (amplified ribosomal RNA gene restriction analysis; cutoff level of 85%) and BOX analysis (cutoff level of 85%) of 130 isolates

  ARDRA group    BOX group   Sampling site   Sample-ID    Closest NCBI database match    Accession No.   Max. identity
  ------------- ----------- --------------- ----------- ------------------------------- --------------- ---------------
  1                  1            KD           47/8          *Micrococcus luteus*         NR_037113.1         99%
  2                  1            DS           49/11     *Corynebacterium propinquum*     NR_037038.1         99%
  3                  1            WB           43/24          *Roseomonas mucosa*         NR_028857.1         99%
  4                  1            DS           49/16       *Staphylococcus hominis*       NR_041323.1         99%
  4                  2            DS           49/9        *Staphylococcus hominis*       NR_041323.1         99%
  4                  3            DS           49/1        *Staphylococcus hominis*       NR_041323.1         99%
  4                  4            KD           47/15        *Staphylococcus caprae*       NR_024665.1        100%
  4                  4            DS           49/13        *Staphylococcus caprae*                             
  4                  5            UU           51/12     *Staphylococcus epidermidis*     NR_036904.1         99%
  4                  5            UU           51/9      *Staphylococcus epidermidis*                           
  4                  5            KD           47/12     *Staphylococcus epidermidis*                           
  4                  5            UU           51/2      *Staphylococcus epidermidis*                           
  4                  5            KD           47/10     *Staphylococcus epidermidis*                           
  4                  5            UU           51/10     *Staphylococcus epidermidis*                           
  4                  5            KD           47/16     *Staphylococcus epidermidis*                           
  4                  5            KD           47/5      *Staphylococcus epidermidis*                           
  4                  5            UU           51/17     *Staphylococcus epidermidis*                           
  4                  5            DS           49/14     *Staphylococcus epidermidis*                           
  4                  5            UU           51/18     *Staphylococcus epidermidis*                           
  4                  5            UU           50/1      *Staphylococcus epidermidis*                           
  4                  5            UU           51/13     *Staphylococcus epidermidis*                           
  4                  5            DS           49/7      *Staphylococcus epidermidis*                           
  4                  5            UU           51/4      *Staphylococcus epidermidis*                           
  4                  5            UU           51/14     *Staphylococcus epidermidis*     NR_036904.1         99%
  4                  5            KD           47/14     *Staphylococcus epidermidis*                           
  4                  6            KD           47/17       *Staphylococcus hominis*       NR_041323.1         99%
  4                  7            KD           47/13        *Staphylococcus caprae*       NR_024665.1         99%
  4                  8            DS           49/10     *Staphylococcus epidermidis*     NR_036904.1        100%
  4                  9            DS           49/6        *Staphylococcus warneri*       NR_025922.1        100%
  4                 10            DS           49/4        *Staphylococcus hominis*                             
  4                 10            UU           50/3        *Staphylococcus hominis*                             
  4                 10            UU           50/2        *Staphylococcus hominis*                             
  4                 10            UU           50/5        *Staphylococcus hominis*       NR_041323.1         98%
  4                 10            DS           49/15       *Staphylococcus hominis*                             
  4                 11            DS           49/3         *Staphylococcus caprae*       NR_024665.1        100%
  4                 12            DS           49/2         *Staphylococcus cohnii*       NR_036902.1        100%
  4                 13            DS           49/8      *Staphylococcus epidermidis*     NR_036904.1        100%
  4                 14            UU           51/6      *Staphylococcus epidermidis*     NR_036904.1        100%
  4                 15            UU           50/4        *Staphylococcus hominis*       NR_041323.1         98%
  5                  1            KD           47/11     *Staphylococcus epidermidis*     NR_036904.1         99%
  6                  1            BG           48/18     *Staphylococcus epidermidis*     NR_036904.1        100%
  7                  1            KO           46/17       *Staphylococcus warneri*       NR_025922.1        100%
  7                  2            KO           46/21     *Staphylococcus epidermidis*     NR_036904.1        100%
  7                  3            KO           46/18       *Staphylococcus hominis*                             
  7                  3            KO           46/19       *Staphylococcus hominis*       NR_036956.1         99%
  8                  1            KO           46/20     *Staphylococcus epidermidis*                           
  8                  1            KO           46/22     *Staphylococcus epidermidis*     NR_036904.1         99%
  9                  1            KD           47/1      *Staphylococcus epidermidis*     NR_036904.1         98%
  9                  1            BG           48/5      *Staphylococcus epidermidis*                           
  9                  1            BG           48/1      *Staphylococcus epidermidis*                           
  9                  2            BG           48/10     *Staphylococcus epidermidis*     NR_036904.1        100%
  9                  3            BG           48/7      *Staphylococcus epidermidis*     NR_036904.1        100%
  9                  4            BG           48/6      *Staphylococcus haemolyticus*    NR_036955.1         99%
  9                  5            BG           48/11       *Staphylococcus hominis*       NR_041323.1         99%
  9                  5            BG           48/12       *Staphylococcus hominis*                             
  9                  5            BG           48/9        *Staphylococcus hominis*                             
  9                  5            BG           48/13       *Staphylococcus hominis*                             
  9                  6            BG           48/3      *Staphylococcus lugdunensis*     NR_024668.1        100%
  10                 1            BG           48/14       *Staphylococcus hominis*       NR_041323.1         99%
  10                 2            BG           48/15       *Staphylococcus hominis*       NR_041323.1         99%
  11                 1            BG           48/2        *Planomicrobium koreense*                            
  11                 1            BG           48/8        *Planomicrobium koreense*      NR_025011.1        100%
  12                 1            UU           51/16         *Bacillus idriensis*         NR_043268.1         99%
  12                 1            UU           51/3          *Bacillus idriensis*         NR_043268.1         99%
  13                 1            KO           46/23     *Paenibacillus barcinonensis*    NR_042272.1         99%
  14                 1            UU           51/15     *Staphylococcus auricularis*     NR_036897.1         99%
  14                 2            UU           51/7      *Staphylococcus auricularis*     NR_036897.1         99%
  15                 1            KD           47/3          *Arthrobacter agilis*        NR_026198.1         98%
  16                 1            UU           51/8       *Bacillus herbersteinensis*     NR_042286.1         96%
  17                 1            WS           42/2        *Staphylococcus hominis*       NR_036956.1         99%
  17                 2            RS           44/11     *Staphylococcus haemolyticus*    NR_036955.1         99%
  17                 3            KO           46/7        *Staphylococcus warneri*       NR_025922.1        100%
  17                 4            WB           43/18       *Staphylococcus hominis*                             
  17                 4            PS           45/5        *Staphylococcus hominis*                             
  17                 4            PS           45/8        *Staphylococcus hominis*                             
  17                 4            WB           43/13       *Staphylococcus hominis*       NR_041323.1         99%
  17                 5            WB           43/17     *Staphylococcus epidermidis*                           
  17                 5            KO           46/16     *Staphylococcus epidermidis*                           
  17                 5            WB           43/2      *Staphylococcus epidermidis*                           
  17                 5            KO           46/3      *Staphylococcus epidermidis*                           
  17                 5            KO           46/15     *Staphylococcus epidermidis*                           
  17                 5            RS           44/3      *Staphylococcus epidermidis*     NR_036904.1        100%
  17                 6            KO           46/6      *Staphylococcus epidermidis*     NR_036904.1         99%
  17                 7            PS           45/6      *Staphylococcus epidermidis*     NR_036904.1        100%
  17                 8            PS           45/7        *Staphylococcus hominis*       NR_041323.1         99%
  17                 9            PS           45/3        *Staphylococcus hominis*       NR_041323.1         98%
  17                10            KO           46/13       *Staphylococcus hominis*                             
  17                10            KO           46/2        *Staphylococcus hominis*                             
  17                10            KO           46/11       *Staphylococcus hominis*       NR_041323.1         98%
  17                11            KO           46/14     *Staphylococcus lugdunensis*     NR_024668.1        100%
  17                12            RS           44/18       *Staphylococcus hominis*                             
  17                12            KO           46/10       *Staphylococcus hominis*                             
  17                12            RS           44/12       *Staphylococcus hominis*                             
  17                12            RS           44/2        *Staphylococcus hominis*                             
  17                12            PS           45/11       *Staphylococcus hominis*                             
  17                12            PS           45/4        *Staphylococcus hominis*                             
  17                12            WS           42/1        *Staphylococcus hominis*                             
  17                12            RS           44/1        *Staphylococcus hominis*       NR_036956.1         99%
  17                12            WB           43/12       *Staphylococcus hominis*                             
  17                12            WB           43/1        *Staphylococcus hominis*                             
  17                13            KO           46/9        *Staphylococcus warneri*       NR_025922.1         99%
  18                 1            WB           43/10     *Staphylococcus epidermidis*     NR_036904.1        100%
  18                 2            RS           44/17     *Staphylococcus epidermidis*     NR_036904.1         97%
  19                 1            RS           44/10        *Staphylococcus caprae*       NR_024665.1         99%
  20                 1            WB           43/4             *Kocuria rosea*                                 
  20                 1            WB           43/5             *Kocuria rosea*           NR_044871.1         99%
  21                 1            WB           43/23         *Bacillus circulans*         NR_042726.1         99%
  21                 2            WB           43/7          *Bacillus circulans*         NR_042726.1         99%
  21                 3            WB           43/16         *Bacillus aerophilus*        GU339271.1          79%
  22                 1            RS           44/14      *Bacillus frigoritolerans*                            
  22                 1            RS           44/4       *Bacillus frigoritolerans*      NR_042639.1        100%
  22                 2            PS           45/10          *Bacillus simplex*          NR_042136.1        100%
  23                 1            BG           48/17       *Staphylococcus hominis*       NR_041323.1         99%
  24                 1            RS           44/16         *Micrococcus luteus*                               
  24                 1            RS           44/5          *Micrococcus luteus*         NR_037113.1         97%
  24                 2            WB           43/6          *Micrococcus luteus*         NR_037113.1         92%
  24                 3            WB           43/3          *Micrococcus luteus*         NR_037113.1         99%
  25                 1            RS           44/8          *Arthrobacter agilis*        NR_026198.1        100%
  26                 1            DS           49/5          *Micrococcus luteus*         NR_037113.1         98%
  26                 2            UU           51/1          *Micrococcus luteus*         NR_037113.1         97%
  27                 1            KD           47/4           *Kocuria palustris*         NR_026451.1         98%
  28                 1            BG           48/16       *Micrococcus antarcticus*      NR_025285.1         99%
  29                 1            BG           48/4        *Micrococcus antarcticus*      NR_025285.1         99%
  30                 1            WB           43/9        *Micrococcus antarcticus*      NR_025285.1         99%
  31                 1            KD           47/7          *Micrococcus luteus*         NR_037113.1         99%
  32                 1            RS           44/9        *Micrococcus antarcticus*      NR_025285.1         99%
  33                 1            KD           47/9          *Micrococcus luteus*         NR_037113.1         99%
  34                 1            RS           44/13          *Kocuria palustris*         NR_026451.1         99%
  35                 1            PS           45/9         *Aerococcus urinaeequi*       NR_043443.1         99%
  36                 1            KO           46/4          *Micrococcus luteus*         NR_037113.1         99%
